https://www.transiticsnews.com/p/connecticut-and-rhode-island-capitulate>On October 13th, the Trump administration’s new rule banning federal funds from being used to cover care for trans youth through Medicaid and CHIP went into effect. Both programs, which are funded jointly by the federal government and individual states, provide health insurance to low-income Americans, and under them, states decide what care they will and will not cover. As the rule stipulates, states wishing to continue covering gender-affirming care for minors must use their own funds to take on “the full cost of sex-rejecting procedures.”>Last month, Transitics reported that Arizona and Virginia had ended coverage of care for trans youth in response to the rule, and a week later, Transitics reported that Colorado and Michigan had joined that list as well. The latter article also identified a dozen states—California, Delaware, Hawaii, Illinois, Maine, Maryland, Massachusetts, New Mexico, New York, Oregon, Vermont, and Washington—that had already announced (or, in Delaware’s case, quietly decided) that they would be continuing coverage using their own funds.>But since then, there’s been a number of new updates, some good and some bad. And we’ll start with the bad. As of today, Transitics can confirm that two more blue states have cut coverage of gender-affirming care for minors: Connecticut and Rhode Island.>Firstly, there’s Connecticut. On October 2nd, the Connecticut Department of Social Services (DSS) published a bulletin to its website informing providers that, because of the new rule, they would have to include a diagnosis code when billing “drug products commonly used for gender affirmation.” After this was posted, Transitics contacted the Connecticut Department of Social Services for clarification and was told that a decision had not yet been made on the issue.